ATE433462T1 - Me-5, me-2, and epp2: menschliche proteinantigene,die mit autoantikörpern reagieren, die im serum von frauen vorliegen, die an endometriose leiden - Google Patents

Me-5, me-2, and epp2: menschliche proteinantigene,die mit autoantikörpern reagieren, die im serum von frauen vorliegen, die an endometriose leiden

Info

Publication number
ATE433462T1
ATE433462T1 AT05254121T AT05254121T ATE433462T1 AT E433462 T1 ATE433462 T1 AT E433462T1 AT 05254121 T AT05254121 T AT 05254121T AT 05254121 T AT05254121 T AT 05254121T AT E433462 T1 ATE433462 T1 AT E433462T1
Authority
AT
Austria
Prior art keywords
endometriosis
epp2
serum
react
human protein
Prior art date
Application number
AT05254121T
Other languages
German (de)
English (en)
Inventor
El Shami A Said
Bruce Campbell
Dennis Sustarsic
Niver Sahakian
Original Assignee
Siemens Healthcare Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics filed Critical Siemens Healthcare Diagnostics
Application granted granted Critical
Publication of ATE433462T1 publication Critical patent/ATE433462T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
AT05254121T 2004-07-07 2005-06-30 Me-5, me-2, and epp2: menschliche proteinantigene,die mit autoantikörpern reagieren, die im serum von frauen vorliegen, die an endometriose leiden ATE433462T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/887,540 US20060008876A1 (en) 2004-07-07 2004-07-07 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis

Publications (1)

Publication Number Publication Date
ATE433462T1 true ATE433462T1 (de) 2009-06-15

Family

ID=35124497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05254121T ATE433462T1 (de) 2004-07-07 2005-06-30 Me-5, me-2, and epp2: menschliche proteinantigene,die mit autoantikörpern reagieren, die im serum von frauen vorliegen, die an endometriose leiden

Country Status (9)

Country Link
US (7) US20060008876A1 (enExample)
EP (1) EP1614692B1 (enExample)
JP (1) JP2006051019A (enExample)
AT (1) ATE433462T1 (enExample)
AU (1) AU2005202925A1 (enExample)
CA (1) CA2509632A1 (enExample)
DE (1) DE602005014828D1 (enExample)
ES (1) ES2326324T3 (enExample)
NZ (1) NZ541063A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329399B2 (en) * 2006-10-27 2012-12-11 Siu K W Michael Endometrial biomarkers
US8279789B2 (en) * 2008-06-10 2012-10-02 Qualcomm Incorporated Intelligent setting of hysteresis activation timer to enter hysteresis sooner and save battery
WO2011085213A2 (en) * 2010-01-07 2011-07-14 Sanford-Burnham Medical Research Institute Pathologically-activated therapeutics
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
GB202310300D0 (en) 2023-07-05 2023-08-16 Univ Edinburgh Endometrosis markers and methods of diagnosing nedometriosis

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US652187A (en) * 1899-11-02 1900-06-19 Sigvald Krohn System of electrical distribution.
US4489166A (en) * 1982-05-27 1984-12-18 Research Corporation Monitoring of human endometrial function by radioimmunoassay of PEP
AU5068090A (en) 1989-03-07 1990-09-13 Adeza Biomedical Corporation Endometriosis diagnosis methods and reagents
US5302738A (en) 1991-03-15 1994-04-12 Hoffmann-La Roche Inc. Chiral phosphines
CA2062675A1 (en) 1991-04-09 1992-10-10 Sandra S. Fenton Endometrial antigen, composition, test kit and method for endometrial antibody determination
WO1994028021A1 (en) * 1993-05-28 1994-12-08 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis
US5877284A (en) * 1993-08-12 1999-03-02 The Trustees Of The University Of Pennsylvania Isolated chemotactic factor from patients with endometriosis
US7122322B2 (en) * 1994-10-25 2006-10-17 The Curators Of The University Of Missouri Endometriosis-specific secretory protein
US6531277B2 (en) * 1994-10-25 2003-03-11 The Curators Of The University Of Missouri Endometriosis-specific secretory protein
US5843673A (en) * 1994-10-25 1998-12-01 Curators Of The University Of Missouri Method of screening for endometriosis
US5618680A (en) * 1994-12-28 1997-04-08 Institut De Medecine De La Reproduction De Montreal Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
US6376201B2 (en) * 1994-12-28 2002-04-23 Procrea Biosciences Inc. Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
WO1997035016A1 (en) 1996-03-18 1997-09-25 Novo Nordisk Biotech Inc Polypeptides having phytase activity and nucleic acids encoding same
WO1997035018A1 (en) 1996-03-21 1997-09-25 New York University Growth factor inducible serine/threonine phosphatase fin13
US6294662B1 (en) * 1996-08-27 2001-09-25 University Of South Florida Nucleic acids encoding an endometrial bleeding associated factor (ebaf)
WO1999004265A2 (en) 1997-07-17 1999-01-28 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides
US6165767A (en) * 1998-03-20 2000-12-26 Incyte Pharmaceuticals, Inc. Protein phosphatase-related molecules
AU760613B2 (en) 1998-06-04 2003-05-22 Reprogen, Inc. Use of prothymosin in the diagnosis and treatment of endometriosis
AU765750B2 (en) * 1998-06-04 2003-09-25 Reprogen, Inc. Use of cathepsin s in the diagnosis and treatment of endometriosis
US6525187B1 (en) * 1998-07-31 2003-02-25 Diagnostic Products Corporation Polynucleotide encoding autoantigens associated with endometriosis
ATE374370T1 (de) 1999-01-25 2007-10-15 Siemens Medical Solutions Diag Verfahren zur diagnose von endometriose
WO2000059547A2 (en) * 1999-04-02 2000-10-12 Center For Molecular Medicine And Immunology Method of detecting endometriosis
WO2000063675A1 (en) 1999-04-16 2000-10-26 Bioincept, Inc. Identification of a serum marker for endometriosis
WO2000075321A2 (en) * 1999-06-03 2000-12-14 Curagen Corporation Polynucleotides and membrane-bound polypeptide encoded thereby
EP1238104A2 (en) 1999-11-03 2002-09-11 Metris Therapeutics Limited Agents implicated in endometriosis
GB0004232D0 (en) 2000-02-24 2000-04-12 Zeneca Ltd Diagnostic method
ES2336817T3 (es) * 2000-02-25 2010-04-16 Siemens Healthcare Diagnostics Inc. Marcadores relacionados con la endometriosis y usos de los mismos.
JP2003532078A (ja) * 2000-04-19 2003-10-28 リサーチ コーポレイション テクノロジーズ，インコーポレイテッド 子宮内膜症の診断アッセイ
WO2001079846A2 (en) * 2000-04-19 2001-10-25 Research Corporation Technologies, Inc. Diagnostic assay for endometriosis
DE10048633A1 (de) 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
US6780594B2 (en) * 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
WO2002068579A2 (en) 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
AU2002320630A1 (en) * 2001-07-17 2003-03-03 University Of Florida Detecting and treating reproductive tract disorders
AU2003295328A1 (en) * 2002-10-02 2004-04-23 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2004087874A2 (en) 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US6843673B1 (en) * 2004-04-30 2005-01-18 Speed Tech Corp. Coaxial connector structure

Also Published As

Publication number Publication date
US20060008876A1 (en) 2006-01-12
US20100062453A1 (en) 2010-03-11
US8030007B2 (en) 2011-10-04
AU2005202925A1 (en) 2006-02-02
EP1614692A2 (en) 2006-01-11
US20070141600A1 (en) 2007-06-21
US7879562B2 (en) 2011-02-01
ES2326324T3 (es) 2009-10-07
EP1614692A3 (en) 2006-04-05
NZ541063A (en) 2008-07-31
CA2509632A1 (en) 2006-01-07
US20080153106A1 (en) 2008-06-26
US20070178528A1 (en) 2007-08-02
DE602005014828D1 (de) 2009-07-23
US20110201129A1 (en) 2011-08-18
US7981626B2 (en) 2011-07-19
US20100330696A1 (en) 2010-12-30
EP1614692B1 (en) 2009-06-10
JP2006051019A (ja) 2006-02-23

Similar Documents

Publication Publication Date Title
Han et al. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma
WO2003024993A3 (en) Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
TW200510459A (en) RG1 antibodies and uses thereof
WO2003000853A3 (en) Protein aggregation assays and uses thereof
WO2004058171A3 (en) Antibodies against gpr64 and uses thereof
US11193942B2 (en) Methods and devices for female health monitoring
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
MX2010013692A (es) Deteccion de uso de cannabis.
BRPI0414030B8 (pt) método para detectar desordens neoplásicas, dispositivos de diagnóstico in vitro, dispositivo híbrido de captura, uso de uma fase sólida, métodos para desenvolver kits e métodos para avaliação de diagnóstico de desordens neoplásicas
DE60335022D1 (de) Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel
WO2004111081A3 (en) Antigenic peptides of sars coronavirus and uses thereof
WO2008014458A3 (en) Protein markers for the diagnosis and prognosis of ovarian and breast cancer
WO2009126969A3 (en) Biomarkers for endometrial disease
WO2022020234A3 (en) Immunoassay for sars-cov-2 neutralizing antibodies and materials therefor
WO2005080985A3 (en) Methods and compositions for detecting and treating autoimmune diseases
WO2000035950A3 (en) Reagents and methods useful for detecting diseases of the breast
ATE433462T1 (de) Me-5, me-2, and epp2: menschliche proteinantigene,die mit autoantikörpern reagieren, die im serum von frauen vorliegen, die an endometriose leiden
WO2007051169A3 (en) Use of b cell expansion agents in generating antibodies
AU6008800A (en) Preparation of spheres for diagnostic tests
EP2527358A3 (en) Diagnostic assay
AU2011291450A8 (en) TAM receptors and TAM receptor ligands in detection and modulation of neuropathological disease
ATE412180T1 (de) Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
WO2003024304A3 (en) Detection and treatment of cancers of the liver
WO2004045364A3 (en) Methods of detecting ovarian neoplasia
WO2004065936A3 (en) Immunoglobulin e detection in mammalian species

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties